GenMark Diagnostics to Present at the 2017 William Blair Growth Stock Conference
May 31 2017 - 5:24PM
Business Wire
GenMark Diagnostics, Inc. (NASDAQ: GNMK), a leading provider of
automated, multiplex molecular diagnostic testing systems, will
present at the 2017 William Blair Growth Stock Conference in
Chicago on Tuesday, June 13, 2017. The presentation will be
delivered by Hany Massarany, President and Chief Executive Officer,
and is scheduled for 3:30 p.m. (CT). The presentation will be made
available at http://ir.genmarkdx.com.
ABOUT GENMARK DIAGNOSTICS
GenMark Diagnostics (NASDAQ: GNMK) is a leading provider of
multiplex molecular diagnostic solutions designed to enhance
patient care, improve key quality metrics, and reduce the total
cost-of-care. Utilizing GenMark's proprietary eSensor® detection
technology, GenMark's eSensor XT- 8® and ePlex® systems are
designed to support a broad range of molecular diagnostic tests
with a compact, easy-to-use workstation and self-contained,
disposable test cartridges. GenMark's ePlex®: The True
Sample-to-Answer Solution™ is designed to optimize laboratory
efficiency and address a broad range of infectious disease testing
needs, including respiratory, bloodstream, and gastrointestinal
infections. For more information, visit www.genmarkdx.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170531006495/en/
GenMark Diagnostics, Inc.Hany MassaranyPresident, Chief
Executive Officer760-448-4325
GenMark Diagnostics (NASDAQ:GNMK)
Historical Stock Chart
From Mar 2024 to Apr 2024
GenMark Diagnostics (NASDAQ:GNMK)
Historical Stock Chart
From Apr 2023 to Apr 2024
